Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented at the American Headache Society 67th Annual Scientific Meeting.“Whenever ...

Patients with migraine with aura show reduced migraine symptoms, less rescue medication use, and more sustained pain relief ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Central nervous system; Peripheral nervous system; Systemic vasculitis; Connective tissue diseases; ... associated to infectious, malignant and connective tissue diseases (Chart 1). The latter cover a ...

STOCKHOLM, SE / ACCESS Newswire / June 12, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...

Chinese scientists have, for the first time, confirmed the existence of microglia in the peripheral nervous system (PNS). This breakthrough provides novel insights into PNS development, opening ...

Reference: Wu Z, Wang Y, Chen W wei, et al. Peripheral nervous system microglia-like cells regulate neuronal soma size throughout evolution. Cell. 2025. doi: 10.1016/j.cell.2025.02.007. This article ...

SHENZHEN, April 7 (Xinhua) -- Chinese scientists have, for the first time, confirmed the existence of microglia in the peripheral nervous system (PNS). This breakthrough provides novel insights ...

More information: Pabitra K. Sahoo et al, Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas ...

In the peripheral nervous system, on the other hand, NPY was found to have the opposite effect, accelerating metabolism and, consequently, energy expenditure," Velloso explains.